278 related articles for article (PubMed ID: 4904075)
1. Propranolol in the therapy of ischaemic heart disease with angina pectoris.
Banerjea JC; Mukherjee SK; Mukherjee TP
Indian Heart J; 1969 Jul; 21(3):259-72. PubMed ID: 4904075
[No Abstract] [Full Text] [Related]
2. New dimension in angina pectoris therapy.
Russek HI
Geriatrics; 1969 Mar; 24(3):81-95. PubMed ID: 4885554
[No Abstract] [Full Text] [Related]
3. Therapy of angina pectoris with propranolol and long-acting nitrates.
Goldbarg AN; Morgan JF; Butterfield TK; Nemickas R; Bermudez GA
Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4990005
[No Abstract] [Full Text] [Related]
4. What constitutes adequate medical therapy for the patient with angina pectoris?
Russek HI
Geriatrics; 1974 Apr; 29(4):109-12 passim. PubMed ID: 4206865
[No Abstract] [Full Text] [Related]
5. A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris.
Hebb AR; Godwin TF; Gunn RW
Can Med Assoc J; 1968 Feb; 98(5):246-51. PubMed ID: 4965821
[No Abstract] [Full Text] [Related]
6. [Double-blind studies with Inderal in angina pectoris].
Moser K; Lujf A
Wien Klin Wochenschr; 1967 May; 79(18):349-52. PubMed ID: 4869793
[No Abstract] [Full Text] [Related]
7. -Receptor antagonists in angina pectoris.
Prichard BN
Ann Clin Res; 1971 Dec; 3(6):344-52. PubMed ID: 4400460
[No Abstract] [Full Text] [Related]
8. [Effects of propranolol and alprenolol in angina pectoris--a double blind study].
Sakakibara H; Matsutani K; Mochizuki S; Kitabatake S; Takagishi S
Jpn Circ J; 1970 Apr; 34(4):319-33. PubMed ID: 4996004
[No Abstract] [Full Text] [Related]
9. A double blind drug trial of LB-46 (visken) in angina pectoris.
Sainani GS; Mukherjee AK
Indian Heart J; 1972 Jun; 24():Suppl 1:192-6. PubMed ID: 4581427
[No Abstract] [Full Text] [Related]
10. A double blind study of Visken LB-46, in the treatment of angina pectoris.
Nair DV
Indian Heart J; 1972 Jun; 24():Suppl 1:183-91. PubMed ID: 4581426
[No Abstract] [Full Text] [Related]
11. Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris.
Heterington DJ; Comerford MB; Nyberg G; Besterman EM
Br Heart J; 1973 Mar; 35(3):320-33. PubMed ID: 4632566
[No Abstract] [Full Text] [Related]
12. Therapy of angina pectoris with propranolol and long-acting nitrates.
Goldbarg AN; Moran JF; Butterfield TK; Nemickas R; Bermudez GA
Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4988122
[No Abstract] [Full Text] [Related]
13. Propranolol in angina pectoris.
Zsotér TT; Beanlands DS
Arch Intern Med; 1969 Nov; 124(5):584-7. PubMed ID: 4981284
[No Abstract] [Full Text] [Related]
14. LB-46 in angina pectoris. A critique of anti-anginal drug assessment.
Ganeshan KP; Xavier KB
Indian Heart J; 1972 Jun; 24():Suppl 1:197-20. PubMed ID: 4147275
[No Abstract] [Full Text] [Related]
15. Superiority of verapamil to propranolol in stable angina pectoris: a double-blind, randomized crossover trail.
Frishman WH; Klein NA; Strom JA; Willens H; LeJemtel TH; Jentzer J; Siegel L; Klein P; Kirschen N; Silverman R; Pollack S; Doyle R; Kirsten E; Sonnenblick EH
Circulation; 1982 Jan; 65(1 Pt 2):I51-9. PubMed ID: 6796289
[No Abstract] [Full Text] [Related]
16. Effect of tolamolol versus propranolol on systolic time intervals in angina.
Aronow WS; Vawter M; Spivack N; Warren M; Laverty W
Curr Ther Res Clin Exp; 1974 Oct; 16(10):1069-76. PubMed ID: 4154826
[No Abstract] [Full Text] [Related]
17. [Clinical experiences with the use of carbochromen in coronary syndrome].
Ivancić R; Persić T; Custović F
Arzneimittelforschung; 1970 Mar; 20():454-6. PubMed ID: 4916580
[No Abstract] [Full Text] [Related]
18. Propranolol in the office treatment of angina pectoris.
Harley BJ; Davies RO
Can Med Assoc J; 1968 Sep; 99(11):527-30. PubMed ID: 4880118
[No Abstract] [Full Text] [Related]
19. The effect of propranolol in the long-term treatment of angina pectoris.
Zeft HJ; Patterson S; Orgain ES
Arch Intern Med; 1969 Nov; 124(5):578-83. PubMed ID: 4981283
[No Abstract] [Full Text] [Related]
20. Propranolol and angina pectoris. An analysis of the different responses to the drug in patients with angina pectoris.
Furberg C; Jacobsson KA
Acta Med Scand; 1967 Jan; 181(6):729-36. PubMed ID: 4952767
[No Abstract] [Full Text] [Related]
[Next] [New Search]
